Clinical Trial

A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study will evaluate the percentage change in body weight from baseline and proportion of subjects achieving ≥ 5% weight loss from baseline after 52 weeks of treatment with Zovaglutide in subjects with overweight/obesity.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-04
notable Trial sites expanded: 25 -> 45 locations 2026-08-04
Trial Details
NCT Number NCT07230119
Lead Sponsor Beijing QL Biopharmaceutical Co.,Ltd
Conditions Overweight , Obesity
Enrollment 755 participants
Start Date 2026-01-16
Primary Completion 2027-05-29 (estimated)
Study Completion 2027-06-26 (estimated)
Updated on ClinicalTrials.gov 2026-08-03